体力活动对晚期肺癌患者疲劳及生活质量的影响:一项随机对照试验
研究纳入112例晚期肺癌患者,按疾病分期、体能状态和中心分层后1:1随机分为常规护理组和常规护理加2个月监督下体力活动与行为改变干预组,主要终点为2个月时疲劳评分。两组在各时间点疲劳、生活质量、症状、身体功能状态及生存均无显著差异;干预组依从性良好但体力活动增加不足。
要点
- 2个月时疲劳评分EX组37.5 vs UC组36.4,差异1.2(95%CI -3.5~5.8,P=0.62),无显著差异。
- 生活质量、症状、身体或功能状态及生存方面两组均无显著差异。
- 干预依从性良好,但干预组体力活动较对照组增加不足。
核心结论
- 干预依从性良好,但干预组体力活动较对照组增加不足,疲劳或生活质量未见差异。
研究设计与样本
- 开放标签随机对照试验,纳入晚期肺癌、东部肿瘤协作组体能状态(PS)≤2、预期寿命>6个月且能完成6分钟步行试验的患者,按疾病分期、PS 0-1 vs 2及中心分层后1:1随机分为常规护理(UC)组或实验干预(EX)组。
- EX组为UC加2个月监督下每周体力活动及行为改变课程;UC组提供营养和体力活动教育材料。
- 共招募112例患者:EX组56例(50.4%),UC组55例(49.5%),1例不符合条件;男性55%,中位年龄64岁(范围34-80),非小细胞肺癌106例(96%),IV期106例(95.5%)。
- 评估在基线、2、4、6个月进行;主要终点为2个月时疲劳(癌症治疗功能评估-疲劳量表FACT-F);研究设计检测FACT-F子量表平均分差异为6;采用线性混合模型意向性治疗分析。
主要发现
- 2、4、6个月时分别有90、73、62例受试者完成评估,两组失访无差异。
- 2、4、6个月时两组疲劳均无显著差异:2个月时平均分EX组37.5 vs UC组36.4,差异1.2(95%CI -3.5~5.8,P=0.62)。
- 生活质量、症状、身体或功能状态及生存方面两组均无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 干预依从性良好,但干预组体力活动较对照组增加不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Physical activity (PA) improves fatigue and quality of life (QOL) in cancer survivors. Our aim was to assess whether a 2-month PA intervention improves fatigue and QOL for people with advanced lung cancer. METHODS: Participants with advanced lung cancer, Eastern Cooperative Oncology Group performance status (PS) ≤2, >6 months life expectancy, and ability to complete six-min walk test, were stratified (disease stage, PS 0-1 versus 2, centre) and randomized (1:1) in an open-label study to usual care (UC) (nutrition and PA education materials) or experimental intervention (EX): UC plus 2-month supervised weekly PA and behaviour change sessions. Assessments occurred at baseline, 2, 4, and 6 months. The primary endpoint was fatigue [Functional Assessment of Cancer Therapy-Fatigue (FACT-F) questionnaire] at 2 months. The study was designed to detect a difference in mean FACT-F subscale score of 6. Analysis was intention-to-treat using linear mixed models. RESULTS: We recruited 112 patients: 56 (50.4%) were randomized to EX, 55(49.5%) to UC; 1 ineligible. Male 55%; median age 64 years (34-80); 106 (96%) non-small cell lung cancer; 106 (95.5%) stage IV. At 2, 4 and 6 months, 90, 73 and 62 participants were assessed, respectively, with no difference in attrition between groups. There were no significant differences in fatigue between the groups at 2, 4 or 6 months: mean scores at 2 months EX 37.5, UC 36.4 (difference 1.2, 95% CI - 3.5, 5.8, P = 0.62). There were no significant differences in QOL, symptoms, physical or functional status, or survival. CONCLUSIONS: Adherence to the intervention was good but the intervention group did not increase their PA enough compared to the control group, and no difference was seen in fatigue or QOL. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry No. ACTRN12609000971235.
引用
- Dhillon HM, Bell ML, van der Ploeg HP, et al. Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann Oncol. 2017. PMID: 28459989. doi:10.1093/annonc/mdx205
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。